Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
2877.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.20
-11%
0.37
vs 0.41
Q4.20
-79%
0.07
vs 0.32
Q2.21
+34%
0.49
vs 0.37
Q4.21
+519%
0.4
vs 0.07
Q2.22
+5%
0.51
vs 0.49
Q4.22
+47%
0.59
vs 0.4
Q2.23
+37%
0.7
vs 0.51
Q4.23
+19%
0.7
vs 0.59
Q2.24
+27%
0.89
vs 0.7
Q4.24
-57%
0.3
vs 0.7
Sales Growth
YoY
Current
Estimates
Q2.20
-13%
1.2B vs 1.4B
Q4.20
+10%
1.5B vs 1.3B
Q2.21
+31%
1.6B vs 1.2B
Q4.21
+14%
1.7B vs 1.5B
Q2.22
+17%
1.8B vs 1.6B
Q4.22
+28%
2.1B vs 1.7B
Q2.23
+32%
2.4B vs 1.8B
Q4.23
-1%
2.1B vs 2.1B
Q2.24
-13%
2.1B vs 2.4B
Q4.24
-20%
1.7B vs 2.1B
Return on Equity
QoQ
Q2.21
+5%
0.05
vs 0.01
Q4.21
+4%
0.04
vs 0.05
Q2.22
+5%
0.05
vs 0.04
Q4.22
+6%
0.06
vs 0.05
Q2.23
+7%
0.07
vs 0.06
Q4.23
+7%
0.07
vs 0.07
Q2.24
+9%
0.09
vs 0.07
Q4.24
+3%
0.03
vs 0.09
Institutionnal Ownership
Quote Panel
Key Metrics
Forecast
133%2025-Revenue
330%2025-EPS
199%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
2877.HK
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.
HKSE
-0.03Â ( -0.36%)
Relative Strenght
Volume Buzz
-14%
Earning Acce
No
Dist 52w H.
23%Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 2877.HK compares to sector?